The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Regulatory News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) Replacement Astrazeneca Plc

27 May 2014 13:32

RNS Number : 1319I
Morgan Stanley Securities Limited
27 May 2014
 



AMENDMENT

 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Securities Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ASTRAZENECA PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

21 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 USD 0.25 ORDINARY

 PURCHASES

 2,490,678

 44.5850 GBP

 42.6400 GBP

 USD 0.25 ORDINARY

 SALES

 3,666,697

 44.5800 GBP

 42.5837 GBP

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 USD 0.25 ORDINARY

 CFD

 LONG

 2,820

 42.5837 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 180

 42.5837 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 880

 42.7852 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,000

 42.7852 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 7,120

 42.7852 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 8,000

 42.7852 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 96,589

 42.8701 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 179,379

 42.8701 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 8,000

 42.9057 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 7,120

 42.9057 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,000

 42.9057 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 880

 42.9057 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 880

 43.0138 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,000

 43.0138 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 7,120

 43.0138 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 8,000

 43.0138 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 23,500

 43.2957 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 3,208

 43.4596 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 96

 43.4800 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 1,769

 43.5179 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 100,000

 43.6364 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 500,000

 43.6364 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,007

 43.6773 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 65,428

 43.7787 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 28,815

 43.8264 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 594,130

 43.8589 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 37,302

 43.9257 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 65,885

 43.9257 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 2,280

 43.9300 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 456

 43.9300 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 10,280

 43.9300 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 8,500

 43.9473 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 50,180

 43.9757 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 69,706

 43.9766 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 2,946

 43.9800 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 1,947

 43.9800 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 3,300

 44.0000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 1,350

 44.0000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 300

 44.0000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 13,250

 44.0683 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 4,019

 44.1687 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 3,822

 44.1907 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 109

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 228

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 2,917

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 116

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 1,173

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 6,876

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 100,000

 44.2236 GBP

 USD 0.25 ORDINARY

 CFD

 LONG

 1,302

 44.2392 GBP

 ADRS

 FUTURE

 PURCHASE

 21

 4,381.7697 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 300

 42.9638 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4,700

 42.9638 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 12

 43.1350 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 96

 43.4800 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 267

 43.6098 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 510

 43.6198 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 29,230

 43.6658 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,455

 43.6972 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,729

 43.7033 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 67,928

 43.7646 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4

 43.7800 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 594,577

 43.8425 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 5

 43.8860 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 69,706

 43.9571 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 61

 43.9612 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 4,007

 43.9683 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 329

 43.9893 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 28,815

 43.9950 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 7,500

 44.0433 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 8,520

 44.0728 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 80,166

 44.1825 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 138

 44.1839 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 28

 44.1839 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 623

 44.1839 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 235

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 584

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 122

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,917

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 10,995

 44.2000 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 736

 44.2012 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 400

 44.2204 GBP

 USD 0.25 ORDINARY

 CFD

 SHORT

 2,722

 489.0000 SEK

 USD 0.25 ORDINARY

 CFD

 SHORT

 195

 490.1000 SEK

 USD 0.25 ORDINARY

 CFD

 SHORT

 988

 490.1992 SEK

 ADRS

 CFD

LONG

 392.00 (Traded in ADR form)

 74.3000 USD

 ADRS

 CFD

LONG

 2,386.00 (Traded in ADR form)

 74.3000 USD

 ADRS

 CFD

SHORT

 750.00 (Traded in ADR form)

 73.6100 USD

 ADRS

 CFD

SHORT

 403.00 (Traded in ADR form)

 73.6700 USD

 ADRS

 CFD

SHORT

 2,457.00 (Traded in ADR form)

 73.6700 USD

 ADRS

 CFD

SHORT

 1,250.00 (Traded in ADR form)

 73.6788 USD

 ADRS

 CFD

SHORT

 500.00 (Traded in ADR form)

 74.4500 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

USD 0.25 ORDINARY

 CALL

 PURCHASE

 284,590

 4,150.0970

 E

 12/06/2014

 0.7162 GBP

USD 0.25 ORDINARY

 PUT

 PURCHASE

 70,000

 4,200.0000

 E

 19/12/2014

 2.5000 GBP

USD 0.25 ORDINARY

 CALL

 SALE

 70,000

 4,653.0000

 E

 19/12/2014

 2.5000 GBP

 ADRS

 PUT

PURCHASE

 300,000

 70.0000

 A

 21/06/2014

 1.6500 USD

 ADRS

 CALL

 SALE

 200,000

 80.0000

 A

 21/06/2014

 1.2500 USD

 ADRS

 CALL

 SALE

 1,100,000

 90.0000

 A

 21/06/2014

 0.3500 USD

 ADRS

 CALL

 SALE

 2,500,000

 77.5000

 A

 21/06/2014

 1.9500 USD

 ADRS

 CALL

 SALE

 1,000,000

 77.5000

 A

 21/06/2014

 2.8950 USD

 ADRS

 CALL

 SALE

 1,000,000

 77.5000

 A

 21/06/2014

 2.9500 USD

 ADRS

 CALL

 SALE

 500,000

 77.5000

 A

 21/06/2014

 2.9500 USD

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

27 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERLLFVFELIDFIS
Date   Source Headline
2nd May 20247:00 amRNSCalquence combination improved PFS in 1L MCL
1st May 20243:00 pmRNSTotal Voting Rights
29th Apr 20247:05 amRNSTruqap recommended for EU breast cancer approval
29th Apr 20247:00 amRNSEnhertu improved PFS in HER2-low and ultralow
25th Apr 20247:00 amRNS1st Quarter Results
11th Apr 20245:30 pmRNSResult of AGM
11th Apr 20247:00 amRNSAstraZeneca increases 2024 dividend by 7%
8th Apr 20247:00 amRNSEnhertu approved in US for HER2+ solid tumours
5th Apr 20247:00 amRNSImfinzi improved OS & PFS in limited-stage SCLC
2nd Apr 20243:00 pmRNSTotal Voting Rights
2nd Apr 20247:05 amRNSVoydeya approved in US
2nd Apr 20247:00 amRNSFDA accepts Dato-DXd BLA for breast cancer
25th Mar 20247:00 amRNSUltomiris approved in the US for NMOSD
19th Mar 20247:00 amRNSAstraZeneca to acquire Fusion
14th Mar 20247:00 amRNSAstraZeneca to acquire Amolyt
12th Mar 202411:00 amRNSDirector/PDMR Shareholding
7th Mar 202411:00 amRNSNotice of AGM
6th Mar 20243:05 pmRNSDirector/PDMR Shareholding
6th Mar 20243:00 pmRNSDirector/PDMR Shareholding
4th Mar 20247:00 amRNSEMA validates Dato-DXd MAAs for NSQ NSCLC and BC
1st Mar 20243:00 pmRNSTotal Voting Rights
26th Feb 20247:00 amRNSVoydeya recommended for EU approval
22nd Feb 20241:15 pmRNSAcquisition of Gracell completed
22nd Feb 202411:00 amRNSDirector/PDMR Shareholding
22nd Feb 20247:00 amRNSAstraZeneca prices a $5bn bond offering
21st Feb 20247:00 amRNSFiling of Form 20-F with SEC
20th Feb 202411:00 amRNSAnnual Financial Report
19th Feb 20243:00 pmRNSAstraZeneca completes acquisition of Icosavax
19th Feb 20247:10 amRNSTagrisso plus chemo approved in US for lung cancer
19th Feb 20247:05 amRNSFDA accepts Dato-DXd BLA for nonsquamous NSCLC
19th Feb 20247:00 amRNSTagrisso improved PFS in Stage III lung cancer
8th Feb 20247:00 amRNSFinal Results
1st Feb 20243:00 pmRNSTotal Voting Rights
2nd Jan 20243:00 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSAstraZeneca acquires Gracell
22nd Dec 20237:00 amRNSWainua (eplontersen) granted first US FDA approval
14th Dec 20233:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:05 amRNSAstraZeneca to acquire Icosavax
1st Dec 20233:05 pmRNSBlock listing Interim Review
1st Dec 20233:00 pmRNSTotal Voting Rights
1st Dec 20237:00 amRNSDiscontinuation of two CRYSTALIZE evidence trials
23rd Nov 20233:00 pmRNSDirector/PDMR Shareholding
17th Nov 20237:00 amRNSTruqap approved in US for HR+ breast cancer
14th Nov 20237:05 amRNSUpdate on PACIFIC-2 Phase III trial for Imfinzi
9th Nov 20233:00 pmRNSDirector Declaration
9th Nov 20237:10 amRNSImfinzi combination improves PFS in liver cancer
9th Nov 20237:05 amRNSAgreement with Eccogene for clinical stage GLP-1RA
9th Nov 20237:00 amRNS9M and Q3 2023 results
1st Nov 20233:00 pmRNSTotal Voting Rights
1st Nov 20237:00 amRNSAstraZeneca cell & gene therapy deal w/ Cellectis

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.